XML 112 R100.htm IDEA: XBRL DOCUMENT v3.22.4
Segment Information - Reportable Segment Information (Detail) - USD ($)
$ in Millions
 12 Months Ended
Feb. 01, 2021
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Segment Reporting Information [Line Items]        
Segment assets   $ 35,407 $ 39,658  
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest   (1,625) 354 $ 441
Restructuring and Other Charges, net   (12) (41) (17)
Gain on Sale of Assets   3 1 (4)
Interest expense   (336) (289) (132)
Other income (expense), net   37 58 7
Revenue   12,440 11,656 5,084
Segment Adjusted Operating EBITDA   2,455 2,425 1,055
Shareholder Activism Related Costs   (3) (7) 0
Business Divestiture Costs   (110) (42) 0
Other Depreciation and Amortization   (1,179) (1,156) (325)
Goodwill, Impairment Loss   (2,250) 0 0
Impairment, Long-Lived Asset, Held-for-Use   (120) 0 0
Global Shared Services Implementation Costs   (5) 0 0
Corporate and Other [Member]        
Segment Reporting Information [Line Items]        
Acquisition Related Costs   4 0 0
Integration Related Costs   (94) (105) (107)
Restructuring and Other Charges, net   (12) (41) (17)
Gain on Sale of Assets   3 1 (4)
Employee separation costs   (11) (29) (3)
Legal Fees   0 0 (3)
Nourish        
Segment Reporting Information [Line Items]        
Restructuring and Other Charges, net   (8) (32) (10)
Goodwill, Impairment Loss   0    
Health & Biosciences        
Segment Reporting Information [Line Items]        
Restructuring and Other Charges, net   (2) (5) 0
Goodwill, Impairment Loss   (2,250)    
Scent [Member]        
Segment Reporting Information [Line Items]        
Restructuring and Other Charges, net   (1) (3) (7)
Goodwill, Impairment Loss   0    
Pharma Solutions        
Segment Reporting Information [Line Items]        
Restructuring and Other Charges, net   (1) (1) 0
Goodwill, Impairment Loss   0    
Operating Segments [Member] | Nourish        
Segment Reporting Information [Line Items]        
Segment assets   17,008 17,449  
Revenue   6,829 6,264 2,886
Segment Adjusted Operating EBITDA   1,176 1,172 599
Operating Segments [Member] | Health & Biosciences        
Segment Reporting Information [Line Items]        
Segment assets   10,877 14,774  
Revenue   2,339 2,329 134
Segment Adjusted Operating EBITDA   634 625 40
Operating Segments [Member] | Scent [Member]        
Segment Reporting Information [Line Items]        
Segment assets   4,310 4,078  
Revenue   2,301 2,254 2,064
Segment Adjusted Operating EBITDA   423 463 416
Operating Segments [Member] | Pharma Solutions        
Segment Reporting Information [Line Items]        
Segment assets   3,212 3,357  
Revenue   971 809 0
Segment Adjusted Operating EBITDA   222 165 0
Nutrition & Biosciences, Inc [Member]        
Segment Reporting Information [Line Items]        
Acquisition Related Costs $ (75)      
Transaction costs     91 29
Nutrition & Biosciences, Inc [Member] | Corporate and Other [Member]        
Segment Reporting Information [Line Items]        
Acquisition Related Costs   0 (91) (29)
Business Combination, Inventory Step-Up Costs   0 (368) 0
Frutarom Industries Ltd. [Member] | Corporate and Other [Member]        
Segment Reporting Information [Line Items]        
Acquisition Related Costs   $ (1) $ (2) $ (1)